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Chronic exposure to high levels of inorganic 
arsenic (iAs) is associated with a wide range 
of human ailments, including cancer, arterio­
sclerosis, hypertension, type 2 diabetes, and 
a variety of skin disorders (Pi et al. 2000; 
Yoshida et al. 2004). The skin is one of the 
organs most sensitive to iAs toxicity. This is 
potentially due to the high affinity of arsenic 
for sulf  hydryl groups, which leads to arsenic 
accumulation and retention in keratin­rich 
skin tissue. Arsenic­induced non  malignant 
skin lesions, including hyper  keratosis and pig­
mentation disorders, are some of the most 
common and earliest signs of chronic iAs 
exposure (Pi et al. 2000; Yoshida et al. 2004). 
The proliferative skin lesions associated with 
human iAs exposure include Bowen’s disease 
and squamous cell or basal cell carcinoma 
[International Agency for Research on Cancer 
(IARC) 1987; Wong et al. 1998]. Although 
iAs is a confirmed human skin toxi  cant, the 
under  lying molecular mechanism(s) is still 
unclear. Accumulating evidence suggests that 
oxidative stress occurs in response to iAs expo­
sure (Pi et al. 2002, 2003) and may be one 
important factor in dermal arsenic toxicity, 
including carcino  genesis. Indeed, evidence of 
arsenic­induced oxidative DNA damage has 
been observed in cell­based systems (Kojima 
et al. 2009; Pi et al. 2005) and in the biologi­
cal samples of rodents and humans (Piao et al. 
2005; Yamauchi et al. 2004).
The nuclear factor–erythroid­2–related 
factors (NRFs) belong to the cap‘n’collar 
(CNC) subfamily of basic­region leucine zip­
per (bZIP) transcription factors, which include 
NRF1 (NFE2L1/LCRF1/TCF11), NRF2 
(NFE2L2), NRF3 (NFE2L3), and the nuclear 
factor–erythroid 2 p45 subunit, as well as 
more distantly related factors such as BTB and 
CNC homology 1 (BACH1) and BACH2 
proteins (Motohashi et al. 2002). Both NRF1 
and NRF2 form hetero  dimers with small 
Maf or other bZIP proteins and bind to cis­ 
acting element(s) termed anti  oxidant or elec­
trophile response elements (AREs; also known 
as EpREs) in the proxi  mal promoters of target 
genes (Motohashi et al. 2002), leading to acti­
vation of transcription (Biswas and Chan 2010; 
Venugopal and Jaiswal 1998). Although NRF3 
can hetero  dimerize with MafK or MafG and 
bind AREs (Chenais et al. 2005; Kobayashi 
et al. 1999), the role of NRF3 in the regula­
tion of ARE­responsive genes remains elusive. 
NRF1 (Wang and Chan 2006) and NRF3 
(Nouhi et al. 2007; Zhang et al. 2009a) are 
targeted to the endo  plasmic reticulum (ER), 
whereas NRF2 is localized primarily to the 
nucleo  plasm and cyto  plasm. Supporting the 
importance of NRF1 in the develop  mental 
process is the finding that loss of NRF1 func­
tion in mice results in late­gestational embry­
onic lethality (Chan et al. 1998). Liver­specific 
disruption of Nrf1 results in the development 
of steato  hepatitis and hepatic neoplasms (Xu 
et al. 2005). In contrast, Nrf2­deficient mice 
are viable but show a higher susceptibility to 
both oxidative damage and chemical carcino­
genesis (Chan and Kan 1999; Chan et al. 
2001; Ramos­Gomez et al. 2001), whereas 
Nrf3­null mice develop normally and reveal 
no obvious pheno  type (Derjuga et al. 2004). 
Fibroblasts derived from Nrf1­mutant embryos 
showed decreased gluta  thione (GSH) levels 
and enhanced sensitivity to the toxic effects 
of oxidants (Chan and Kwong 2000; Kwong 
et al. 1999), suggesting critical roles for NRF1 
in cellu  lar oxidative defense.
Previous studies (Aono et al. 2003; Du 
et al. 2008), including our own (Pi et al. 2003; 
Fu et al. 2010), have demonstrated that NRF2 
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Ba c k g r o u n d: Human exposure to inorganic arsenic (iAs), a potent oxidative stressor, causes   various 
dermal disorders, including hyperkeratosis and skin cancer. Nuclear factor–erythroid 2–  related fac-
tor 1 (NRF1, also called NFE2L1) plays a critical role in regulating the expression of many anti-
oxidant response element (ARE)-dependent genes.
oBjectives: We investigated the role of NRF1 in arsenic-induced antioxidant response and cyto-
toxicity in human keratinocytes.
re s u l t s: In cultured human keratinocyte HaCaT cells, inorganic arsenite (iAs3+) enhanced the pro-
tein accumulation of long isoforms (120–140 kDa) of NRF1 in a dose- and time-dependent fashion. 
These isoforms accumulated mainly in the nuclei of HaCaT cells. Selective deficiency of NRF1 by 
lentiviral short-hairpin RNAs in HaCaT cells [NRF1-knockdown (KD)] led to decreased expres-
sion of γ-glutamate cysteine ligase catalytic subunit (GCLC) and regulatory subunit (GCLM) and 
a reduced level of intra  cellular glutathione. In response to acute iAs3+ exposure, induction of some 
ARE-dependent genes, including NAD(P)H:quinone oxidoreductase 1 (NQO1), GCLC, and GCLM, 
was significantly attenuated in NRF1-KD cells. However, the iAs3-induced expression of heme oxy-
genase 1 (HMOX-1) was unaltered by silencing NRF1, suggesting that HMOX-1 is not regulated by 
NRF1. In addition, the lack of NRF1 in HaCaT cells did not disturb iAs3+-induced NRF2 accumula-
tion but noticeably decreased Kelch-like ECH-associated protein 1 (KEAP1) levels under basal and 
iAs3+-exposed conditions, suggesting a potential interaction between NRF1 and KEAP1. Consistent 
with the critical role of NRF1 in the transcriptional regulation of some ARE-bearing genes, knock-
down of NRF1 significantly increased iAs3+-induced cytotoxicity and apoptosis.
co n c l u s i o n s: Here, we demonstrate for the first time that long isoforms of NRF1 contribute 
to arsenic-induced antioxidant response in human keratinocytes and protect the cells from acute 
  arsenic cytotoxicity.
key w o r d s : apoptosis, arsenic, cytotoxicity, KEAP1, keratinocyte, NRF1, NRF2, oxidative stress. 
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is a key player in the cellular adaptive response 
to inorganic arsenite (iAs3+)­induced oxidative 
stress. In contrast, the role of NRF1 in arsenic­
induced anti  oxidant response and cyto  toxicity 
has not been established. In the present study, 
we examined the distinctive roles of NRF1 in 
iAs3+­induced anti  oxidant response, cytotox­
icity, and apoptosis, as well as the inter  play 
between NRF1 and NRF2, in response to 
iAs3+ exposure, using HaCaT cells, a human 
keratino  cyte cell line that models the skin as 
a target of iAs. In this study, we found direct 
evidence that iAs3+ activates both the NRF1­ 
and NRF2­mediated anti  oxidant responses, 
which protects the cells from acute arsenic 
cyto  toxicity. This indicates for the first time 
that NRF1 is a novel target of iAs3+ exposure. 
The results of this study provide important 
insights into the initial molecular response 
to iAs3+ in the target cells of arsenic toxicity 
and carcino  genicity.
Materials and Methods
Reagents and cell culture. We purchased 
sodium arsenite, sulforaphane (SFN), and 
tert-butyl	 hydro	 quinone	(tBHQ)	from	Sigma	
Chemical Co. (St. Louis, MO, USA) and 
tunica  mycin (TU), thapsigargin (TG), and 
brefeldin A (BFA) from Calbiochem (San 
Diego, CA, USA). HaCaT cells, a sponta­
neously immortalized human epithelial cell 
line developed by Boukamp et al. (1988) were 
obtained from N.E. Fusening, German Cancer 
Research Center, Heidelberg, Germany. The 
cells were cultured in Dulbecco’s modified 
Eagle’s medium supplemented with 10% 
fetal bovine serum, 100 U penicillin/mL, 
and 100 µg streptomycin/mL, as previously 
described (Pi et al. 2003). Cultures were main­
tained at 37°C in a humidified 5% CO2 atmo­
sphere. Culture media, fetal bovine serum, and 
supplements were purchased from Invitrogen 
(Carlsbad, CA, USA). The stock solutions of 
chemicals used in the current study were pre­
pared in culture medium or 0.5% dimethyl 
sulfoxide (DMSO) in medium (vehicle). 
Lentiviral-based short-hairpin RNA 
(shRNA)  transduction.  We  obtained 
MISSION shRNA lentiviral particles from 
Sigma. Lentiviral transduction of HaCaT cells 
with particles for shRNAs targeting NRF1 
(SHVRS­NM_003204) or scrambled non­
target negative control (sh­Scr; SHC002V) 
was performed as described previously (Woods 
et al. 2009). The cells were maintained in 
medium containing 1.0 µg/mL puromycin.
Quantitative real-time reverse-transcriptase 
polymerase chain reaction (RT–PCR) analy-
sis. Total RNA was isolated with TRIzol 
(Invitrogen) and then subjected to cleanup 
using the RNase­Free DNase Set and RNeasy 
Mini	Kit	(Qiagen,	Valencia,	CA, USA). 
Quantitative	real-time	RT-PCR	was	per­
formed as described previously (Woods et al. 
2009). The primers {NRF1 [GenBank acces­
sion no. NM_003204 (National Center 
for Biotechnology Information. 2010)], 
HMOX1 (heme oxygenase 1; NM_002133), 
NQO1	(NM_000903),	SRX (sulfiredoxin 1; 
NM_080725), GCLC (γ­glutamate cysteine 
ligase catalytic subunit; NM_001498), and 
GCLM (γ­glutamate cysteine ligase regula­
tory subunit; NM_002061), described in 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1002304)} were designed using Primer 
Express 3 (Applied Biosystems, Carlsbad, CA, 
USA) and synthesized by MWG­Biotech Inc. 
(High Point, NC, USA). Real­time fluorescence 
detection was carried out using an ABI PRISM 
7900 Sequence Detector (Applied Biosystems).
Western blot analysis. Isolation of cell frac­
tions and Western blotting were performed as 
described previously (Pi et al. 2003; Woods 
et al. 2009). Briefly, whole­cell lysates (50 µg 
protein) were separated on 4–12% Tris­glycine 
gels. Antibodies for NRF1 (H­285) (sc­13031; 
1:500), NRF2 (sc­13032; 1:500), and Kelch­
like ECH­associated protein 1 (KEAP1; 
sc­15246; 1:500) were from Santa Cruz 
Biotechnology Inc. (Santa Cruz, CA, USA). 
Antibodies for GRP78/BIP (glucose­regulated 
protein, 78 kDa/binding immuno  globulin 
protein; no. 3177; 1:1,000) and CHOP 
(CCAAT/enhancer­binding protein homolo­
gous protein; no. 2895; 1:1,000), both down­
stream protein markers for ER stress, were 
purchased from Cell Signaling Technology, 
Inc. (Danvers, MA, USA). Antibodies for 
lamin A (L1293; 1:2,500), β­actin (A1978; 
1:2,000), and α­tubulin (T5168; 1:2,000) 
were purchased from Sigma. Antibody for 
GCLC (RB­1697; 1:800) was obtained from 
Lab Vision (Fremont, CA, USA). 
Chromatin immunoprecipitation assay. We 
performed ChIP analyses using the EZ ChIP 
kit (Upstate Biotechnology, Temecula, CA, 
USA) according to the manufacture’s protocol. 
PCR amplification was carried out for 40 cycles 
with 5 µL of sample DNA solution, and PCR 
products were separated on 3% agarose gels 
in Tris–acetate–EDTA buffer. Two primers 
were used to amplify the segment flanking an 
active ARE site on NAD(P)H:quinone oxido­
reductase 1 (NQO1) promoter with forward 
primer 5´­attacctgccttgaggagca­3´ and reverse 
primer 5´­cggattactgtggtgcccta­3´, which   
generate a 206­bp product.
Acute cytotoxicity assay. A minimum of 
five replicates of 10,000 cells/well were plated 
in 96­well plates and allowed to adhere to the 
plate for 24 hr, at which time the medium 
was removed and replaced with fresh serum­
free medium containing arsenic compounds. 
Cells were then incubated for an additional 
24 hr, and cell viability was determined 
using the CellTiter Non­Radioactive Cell­
Proliferation Assay Kit with MTT [3­(4,5­
dimethyl  thiazol­2­yl)­2,5­diphenyltetrazolium 
bromide] (Promega, Madison, WI, USA). 
Measurements are expressed as a percentage of 
the untreated control of corresponding cells. 
The LC50 (concentration lethal to 50% of 
cells) values were determined from analysis of 
the log­linear phase of the curves. 
Determination of apoptosis by flow cytom-
etry. Cells were seeded in a six­well plate and 
grown to approximately 80% confluence. 
After 20 hr of iAs exposure, the floating and 
attached cells were harvested for apoptosis 
analysis. We detected phosphatidyl  serine on 
the outer leaflet of apoptotic cells using the 
TACS Annexin V­FITC (fluorescein isothio­
cyanate) Apoptosis Detection Kit (Trevigen, 
Gaithersburg, MD, USA) as described pre­
viously (Pi et al. 2005). For each sample, 
10,000 cells were examined by flow cytom­
etry (Becton Dickinson FACSVantage; BD 
Biosciences, San Jose, CA, USA). We deter­
mined the percentage of apoptotic cells by sta­
tistical analysis of the various dot plots using 
CellQuest	software	(BD	Biosciences).	
ARE  reporter  assay.  We  obtained 
Cignal Lenti ARE reporter, which expresses 
a luciferase gene driven by multiple ARE 
(TCACAGTGACTCAGCAAAATT) repeats, 
from SABiosciences (Frederick, MD, USA). 
Lentiviral transduction of HaCaT cells was 
performed as described previously (Woods 
et al. 2009). Cells were grown to approximately 
90% confluency and sub  cultured in medium 
containing 1.0 µg/mL puromycin. The 
luciferase activity was measured by Luciferase 
Reporter Assay System (Promega) according 
to the manu  facturer’s protocol. The luciferase 
activity was normalized to cell viability that 
was determined using the Non­Radioactive 
Cell­Proliferation Assay Kit (Promega).
Statistical analyses. We performed all sta­
tistical analyses using GraphPad Prism, ver­
sion 5 (GraphPad Software, San Diego, CA, 
USA), with p < 0.05 taken as significant. More 
specific indices of statistical significance are 
indicated in individual figure legends. Data 
are expressed as mean ± SE. For comparisons 
among groups, we performed one­way analysis 
of variance with Bonferroni post hoc testing. 
Results
iAs3+ increases nuclear NRF1 accumula  tion. 
Based on the Ensembl database (Wellcome 
Trust Sanger Institute/European Bioinformatics 
Institute 2010), the human NRF1 gene con­
tains six exons, transcribes three splice vari­
ants, and translates into three proteins, 
NRF1­1, NRF1­2, and NRF1­3, with 742, 
772, and 791 amino acids, respectively [see 
Supplemental Material, Table 2 (doi:10.1289/
ehp.1002304)]. The predicted molecular 
weights (MWs) of NRF1­1, NRF1­2, and 
NRF1­3 are 81.5, 84.7, and 86.9 kDa, respec­
tively. However, our immuno  blots (Figure 1), 
using an antibody developed against an epitope Zhao et al.
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corresponding to amino acids 191–475 map­
ping near the N­terminus of human NRF1, 
showed that multiple bands with apparent 
MWs approximately 120–140 kDa were dra­
matically diminished by knockdown (KD) of 
NRF1 using lentiviral shRNA targeting human 
NRF1 in HaCaT cells (NRF1­KD), suggest­
ing that these immuno  reactive bands repre­
sent endogenous human NRF1. Interestingly, 
these NRF1 protein bands significantly 
increased in response to iAs3+ but only margin­
ally	responded	to	tBHQ	and	SFN	exposure.	
In addition, in response to iAs3+ treatment, a 
78­kDa protein exhibited a pattern similar to 
that of the bands at 120–140 kDa (Figure 1). 
However, this protein was not detectable in 
nuclear fractions (data not shown), suggesting 
that this protein, if it represents an isoform 
of NRF1, is not associated with NRF1 tran­
scriptional activity. Although we also observed 
multiple bands between 22 and 78 kDa on 
the blot, these bands lack correspondence to 
NRF1 silencing and were unaltered by iAs3+ 
exposure, suggesting that they may represent 
non  specific binding of the antibody used for 
Western blot analysis. A 65­kDa isoform of 
mouse NRF1 has previously been identified 
and shown to potentially function as a domi­
nant negative inhibitor of ARE­mediated tran­
scription (Wang et al. 2007).
To investigate the involvement of NRF1 
in iAs3+­induced antioxidant response in 
human keratinocytes, we meas  ured the dose 
response and time course of iAs3+­induced 
NRF1 accumulation. As shown in Figure 2A, 
exposure to iAs3+ resulted in NRF1 protein 
accumulation in HaCaT cells in a time­ and 
dose­  dependent fashion that reached a peak 
at 6 hr. Consistent with our previous study 
(Pi et al. 2003), the same iAs3+ treatment also 
concomitantly induced NRF2 protein accu­
mulation in a pattern similar to that of NRF1 
(Figure 2A). Because nuclear accumulation is 
essential for a nuclear factor’s transcriptional 
activity, we determined the levels of NRF1 and 
NRF2 in sub  cellular fractions after iAs3+ expo­
sure. We detected iAs3+­induced NRF1 and 
NRF2 mainly in nuclear fractions (Figure 2B), 
suggesting that NRF1 functions as a tran­
scription factor, as does NRF2, in response to 
iAs3+ exposure. To determine the transcrip­
tional activity of NRF1 and NRF2, we assessed 
the activity of the Cignal Lenti ARE reporter, 
which is designed to monitor the activity of 
the anti  oxidant response signal transduction 
pathway in cultured cells. HaCaT cells sta­
bly transduced with the ARE reporter showed 
a dose­ and time­dependent induction of 
luciferase	activity	after	tBHQ	and	SFN	treat­
ment, confirming that the cells are respon­
sive to ARE activation [Figure 2C; see also 
Supplemental Material, Figure 1 (doi:10.1289/
ehp.1002304)]. Consistent with the finding 
that iAs3+ strongly induced nuclear accumula­
tion of both NRF1 and NRF2 (Figure 2A,B) 
Figure 1. Representative image of NRF1 immuno-
blots with whole-cell lysates derived from NRF1-KD 
and Scr control HaCaT cells. Cells were treated 
with vehicle (medium), 20 µM iAs3+, 50 µM tBHQ, or 
7.5 µM SFN for 6 hr. Whole-cell lysates (50 µg pro-
tein) were separated on 4–12% Tris-glycine gels and 
detected using anti-NRF1. β-Actin was used as a 
loading control, and SeeBlue Plus2 (Invitrogen) was 
used as an MW marker. 
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but tBHQ	and	SFN	are	weak	inducers	of	
NRF1 (Figures 1 and 2B), we found iAs3+ to 
be a more potent activator for the ARE reporter 
than	tBHQ	and	SFN	(Figure 2C; see also 
Supplemental Material, Figure 1). To further 
confirm that NRF1 can bind to ARE, we per­
formed a ChIP assay targeting an active ARE 
site on NQO1 promoter (Dhakshinamoorthy 
and Jaiswal 2000). As shown in Figure 2D, 
acute iAs3+ exposure increased the binding of 
NRF1 with the ARE site of NQO1 promoter.
Effect of ER stressors on NRF1 protein 
modification. Previous studies have reported 
that NRF1 is a glycosylated protein sequestered 
in the ER and that ER stressors, including TU, 
BFA, and TG, have been found to affect the 
glycosylation status of recombinant human or 
murine NRF1 (Wang and Chan 2006; Zhang 
et al. 2009b). To study whether endogenous 
human NRF1 is regulated by the same mecha­
nism, we investigated the effect of ER stressors 
on the migration of iAs3+­induced NRF1 using 
SDS­PAGE. As shown in Figure 3A, treat­
ment of HaCaT cells with TU, an inhibitor 
of N­linked protein glycosylation (Shang et al. 
2002), resulted in a faster migration of NRF1 
proteins. In contrast, BFA, which blocks pro­
tein transport from the ER to Golgi (Li et al. 
2006), led to accumulation of slower migrat­
ing NRF1, whereas TG, which blocks ER 
uptake of calcium by inhibiting sarcoplasmic/ 
endoplasmic Ca2+­ATPase (Thastrup et al. 
1990), did not affect NRF1 migration but 
slightly decreased iAs3+­induced NRF1 accu­
mulation. To evaluate the effects of NRF1 
modification by ER stressors on its transcrip­
tional activity, we assessed nuclear NRF1 accu­
mulation and ARE­reporter activity in HaCaT 
cells exposed to iAs3+ with TU, BFA, or TG. 
We observed the 120–140 kDa forms of 
NRF1 mainly in nuclear fractions (Figure 3B), 
suggesting that these forms may retain tran­
scriptional activity. In contrast, we detected 
the slower migrating NRF1 induced by BFA 
mostly in cyto  solic fractions (Figure 3C). 
Although TU + iAs3+–induced faster­migrat­
ing forms of NRF1 were detectable in nuclear 
fractions, the levels of these forms were much 
lower than those of the 120–140 kDa forms in 
nuclear fractions induced by iAs3+ alone or by 
TG + iAs3+ (Figure 3B). Consistent with the 
findings in immuno  blots, all three ER stressors, 
which induced ER stress response at the con­
centrations used [see Supplemental Material, 
Figure 2 (doi:10.1289/ehp.1002304)], signifi­
cantly reduced basal and iAs3+­induced ARE­
reporter activity (Figure 3D). 
Because NRF2 is another important tran­
scription factor for ARE activation (Pi et al. 
2003), we determined the effect of ER stres­
sors on NRF2 expression. In contrast to the 
varied effects on NRF1, the three ER stressors 
had no obvious effect on NRF2 migration on 
SDS­PAGE (Figure 3A–C), suggesting that 
no protein modification occurred in NRF2. 
However, TU and BFA slightly enhanced basal 
NRF2 protein level, whereas TG decreased it 
(Figure 3A). Under iAs3+­exposed conditions, 
TU and TG obviously reduced NRF2 lev­
els in whole­cell lysates and nuclear fractions, 
whereas BFA had little effect (Figure 3B).
Involvement of NRF1 in iAs3+-induced 
anti  oxidant response. To study the role of 
NRF1 in iAs3+­induced antioxidant response 
and cyto  toxicity, we performed lenti  viral 
shRNA­mediated knockdown of NRF1 
in HaCaT cells, using five shRNAs against 
NRF1 for transduction [see Supplemental 
Material, Table 3 and Figure 3 (doi:10.1289/
ehp.1002304)]. One of the constructs (sh­
NRF1-5) markedly silenced NRF1 expres­
sion compared with Scr (sh­Scr), whereas the 
other four constructs had a moderate silencing 
effect. Because the level of NRF1 protein is 
barely detectable in untreated cells and even 
in	tBHQ-	or	SFN-challenged	cells	(Figure	1),	
the efficiency of knockdown by sh­NRF1-5 
(NRF1­KD cells) was confirmed by notably 
diminished induction of NRF1 caused by 
iAs3+ exposure (Figure 1; see also Supplemental 
Material, Figure 3B). Furthermore, the expres­
sion of NRF1 downstream targets GCLC and 
GCLM were attenuated (see Supplemental 
Material, Figure 3C,D), indicating that NRF1 
activity is suppressed in NRF1­KD cells. Along 
with the reduction of GCLC and GCLM, 
the intra  cellular GSH level was significantly 
reduced by silence of NRF1 (see Supplemental 
Material, Figure 3E), confirming that NRF1 is 
critical in regulation of GSH synthesis.
To define the molecular basis for how 
NRF1 is involved in cellular oxidative defense 
against acute iAs3+ toxicity, NRF1­KD and 
Scr cells were acutely exposed to iAs3+; we 
then determined the inducible expression of 
ARE­dependent genes, including HMOX1, 
NQO1, SRX, GCLC, GCLM, and NRF1, 
at mRNA (Figure 4) and protein levels [see 
Figure 4. NRF1 regulates some ARE-dependent genes induced by iAs3+ in HaCaT cells. (A) Time course 
of ARE-dependent gene expression induced by 10 µM iAs3+. (B) Dose response of iAs3+-induced ARE-
dependent gene expression; cells were exposed to vehicle (medium) or iAs3+ for 6 hr. The number in 
parentheses after each gene name is the Ct (cross threshold) value of that gene in Scr cells. 
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Supplemental Material, Figure 3 (doi:10.1289/
ehp.1002304)]. In Scr cells, iAs3+ dose­ and 
time­dependently increased NRF1 protein 
levels (Figure 5) and enhanced the mRNA 
levels of ARE­dependent genes (Figure 4). 
Knockdown of NRF1 substantially decreased 
NRF1 accumulation (Figure 5) and the expres­
sion of NQO1, GCLC, and GCLM under 
basal and iAs3+­exposed conditions (Figure 4). 
Interestingly, induction of HMOX1 caused by 
iAs3+ did not depend on NRF1 (Figure 4).
A previous study (Leung et al. 2003) 
revealed that NRF1 and NRF2 have over­
lapping roles in regulating basal expression 
of ARE­dependent genes. Thus, we studied 
the cross talk of NRF1 with NRF2, as well as 
with KEAP1, a well­known negative regula­
tor of NRF2 transcriptional activity (Hayes 
and McMahon 2009). As shown in Figure 5, 
silencing of NRF1 in HaCaT cells did not 
disturb iAs3+­induced NRF2 accumulation. 
However, lack of NRF1 decreased protein lev­
els of KEAP1 under basal and iAs3+­challenged 
conditions, although KEAP1 was not affected 
by iAs3+ treatment. 
iAs3+-induced cytotoxicity and apoptosis 
in NRF1-deficient HaCaT cells. To inves­
tigate the roles of NRF1 in iAs3+­induced 
cyto  toxicity, we measured the acute (24 hr) 
effect of iAs3+ on cell metabolic integrity in 
NRF1­KD cells. Selective deficiency of NRF1 
in HaCaTs significantly enhanced the sensi­
tivity to iAs3+ toxicity (Figure 6A). The LC50 
value (mean ± SE) was 28.62 ± 3.06 µM in 
NRF1­KD cells, whereas it was 35.99 ± 2.11 
µM in Scr cells. To further substantiate these 
findings, we meas  ured iAs3+­induced apop­
tosis and necrosis using flow cytometry with 
Annexin V­FITC and propidium iodide 
double staining. Consistent with the results 
of cytotoxicity, the knockdown of NRF1 in 
HaCaT cells significantly enhanced the sensi­
tivity to iAs3+­induced apoptosis [Figure 6B; 
see also Supplemental Material, Figure 4 
(doi:10.1289/ehp.1002304)].
Discussion
NRF1 is a ubiquitously expressed transcrip­
tion factor that occurs in a wide range of 
tissues (Biswas and Chan 2010; Luna et al. 
1994). Skin is a major target organ for the 
chronic toxic and carcinogenic effects of iAs 
(Yoshida et al. 2004). Our previous stud­
ies revealed that chronic induction of ARE­
dependent genes may be linked to acquired 
apoptotic resistance and malignant transfor­
mation of keratino  cytes following iAs3+ expo­
sure, whereas NRF2 has been recognized as a 
key transcription factor in iAs3+­induced anti­
oxidant response (Pi et al. 2003, 2007, 2008). 
The present study provides the first demon­
stration that long isoforms (120–140 kDa) of 
NRF1 also contribute to iAs3+­induced anti­
oxidant response in human keratino  cytes and 
suggests that activation of NRF1 is potentially 
involved in chronic dermal arsenic toxicity.
Hyperkeratosis and cancer are the most 
common human skin disorders caused by 
chronic iAs exposure (IARC 1987; Pi et al. 
2000; Wong et al. 1998; Yoshida et al. 
2004). However, the under  lying mechanism 
is unclear. It has been reported that disrup­
tion of Keap1 in mice leads to skin hyper­
keratosis, most likely because of constitutive 
activation of NRF2 and aberrant expression 
of some ARE­dependent cytokeratins (Itoh 
et al. 2003). In humans, increased expres­
sion of ARE­dependent genes, resulting from 
mutations in KEAP1 and/or NRF2, has been 
linked to a malignant pheno  type in the lung 
and other organs (Kwak and Kensler 2009. 
Padmanabhan et al. 2006; Shibata et al. 2008a, 
2008b; Singh et al. 2006; Stacy et al. 2006). 
Given the importance of NRF1 (Figure 4) 
and NRF2 (Pi et al. 2003) in regulating the 
expression of ARE­dependent genes induced 
by iAs3+, it is highly possible that NRF1 and/
or NRF2 activation plays a pathogenic role in 
skin dis  orders chronically induced by arsenic 
exposure, including carcinogenesis, although 
additional research is required to confirm this.
Apoptosis normally functions to control 
the integrity of cell populations by eliminating 
aberrant clones, whereas failure of apoptosis 
likely is a key contributor to tumor initiation 
and progression, as well as drug resistance in 
skin cancer and cancer in general (Guzman 
et al. 2003; Hanahan and Weinberg 2000). 
Thus, an acquired, generalized apoptotic resis­
tance is an important event in the process of 
arsenic­induced malignant transformation (Pi 
et al. 2008). Our previous data indicated that 
HaCaT cells chronically treated with iAs3+ 
show a generalized resistance to apoptosis 
and malignant transformation, which may be 
associated with enhanced basal NRF2 activ­
ity (Pi et al. 2005, 2008). Here, for the first 
time we report that NRF1 also contributes to 
iAs3+­induced ARE­dependent gene expres­
sion and protects cells from acute arsenic tox­
icity, suggesting that NRF1 may be another 
key transcription factor in arsenic carcino­
genesis. However, whether NRF1 activation 
is involved in acquired apoptotic resistance in 
malignant transformation induced by chronic 
iAs3+ exposure needs further study.
It has been predicted that human NRF1 
gene may transcribe at least four different 
transcripts with alterative first exons, differ­
ential splicing, and alterative poly  adenylation 
(Biswas and Chan 2010). In addition to the 
long isoforms as we observed in HaCaT cells, 
a 65­kDa isoform of mouse NRF1 has been 
identified and shown to potentially function 
Figure 5. Effect of iAs3+ on protein expression of NRF1, NRF2, and KEAP1 in Scr and NRF1-KD cells. HaCaT 
cells were exposed to vehicle (medium) or 10 µM iAs3+ for indicated times (A) or to vehicle (medium) or 
indicated concentrations of iAs3+ for 6 hr (B). 
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
S
c
r
N
R
F
1
-
K
D
Vehicle 2612
iAs3+ (10 µM)
18 24 (hr) Vehicle 1.25 2.5 51 02 04 0
iAs3+ (µM)
NRF1
NRF2
KEAP1
β-Actin
NRF1
NRF2
KEAP1
β-Actin
Figure 6. NRF1-KD cells are sensitized to iAs3+ cytotoxicity. (A) Cell viability in response to 24-hr iAs3+ expo-
sure measured by MTT (n = 6). (B) Quantification of iAs3+-induced apoptosis determined by flow cytometry. 
Cells were exposed to iAs3+ for 20 hr; annexin V–positive cells were quantified as apoptosis cells (n = 3). 
*p < 0.05 compared with Scr cells exposed to the same concentration of iAs3+.
iAs3+ (µM) iAs3+ (µM)
150
100
50
0
150
100
50
0
C
e
l
l
 
v
i
a
b
i
l
i
t
y
 
(
%
 
o
f
 
v
e
h
i
c
l
e
)
A
p
o
p
t
o
t
i
c
 
c
e
l
l
s
 
(
%
 
o
f
 
t
o
t
a
l
)
Scr
NRF1-KD
*
*
*
*
* *
*
51 02 04 06 0 10 20 40 60 80 Vehicle VehicleNRF1 and arsenic-induced antioxidant response
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 1 | January 2011  61
as a dominant negative inhibitor of ARE­
mediated transcription (Wang et al. 2007). 
Although we observed two bands close to 
65 kDa on Western blots in the present study 
(Figure 1), neither corresponded to NRF1 
silencing or were altered by iAs3+ exposure, 
suggesting that they may represent non  specific 
binding of the anti  body used for analysis. This 
discrepancy, which could be due to differences 
in cell types, treatment, and anti  bodies used 
for immuno  blotting, needs further study.
Previous studies have suggested that NRF1 
is sequestered in ER and that oxidative stress 
activates NRF1 by permitting accumulation 
into the nucleus (Biswas and Chan 2010). 
The ER is a central organelle as the place of 
lipid synthesis, protein folding, and protein 
maturation (Banhegyi et al. 2007). As a major 
intra  cellular calcium storage compartment, the 
ER also plays a critical role in maintenance of 
cellu  lar calcium homeo  stasis (Li et al. 2006). 
ER stress (conditions interfering with the func­
tion of ER) can be induced by accumulation 
of unfolded proteins and excessive protein traf­
fic (Banhegyi et al. 2007; Li et al. 2006). ER 
stress could also be elicited in the cell culture 
system by pharmaco  logi  cal agents, including 
TU, BFA, and TG, through distinct molecular 
mechanisms (Li et al. 2006; Shang et al. 2002; 
Thastrup et al. 1990). Consistent with previous 
studies using recombinant human or murine 
NRF1 (Wang and Chan 2006; Zhang et al. 
2009b), treatment of HaCaT cells with TU, 
an inhibitor of N­linked protein glycosylation 
(Shang et al. 2002), resulted in faster migration 
of NRF1 isoforms on SDS­PAGE, suggest­
ing that long isoforms of endogenous human 
NRF1 are glycosylated proteins. In contrast, 
BFA, which blocks protein transport from ER 
to Golgi (Li et al. 2006), led to accumulation 
of slower migrating NRF1 proteins, suggesting 
that NRF1 may be further glycosylated in ER 
if its transportation to Golgi is blocked. TG, 
which blocks ER uptake of calcium by inhibit­
ing sarcoplasmic/endoplasmic Ca2+­ATPase 
(Thastrup et al. 1990), slightly decreased 
iAs3+­induced NRF1 accumulation but did 
not affect migration on SDS­PAGE. The find­
ing that ER stressors TU, BFA, and TG affect 
NRF1 migration on SDS­PAGE differently 
suggests that ER stress may not be a common 
mechanism for NRF1 modification. Although 
ER is an important organelle for NRF1 post­
translational modification and may be involved 
in NRF1­mediated anti  oxidant response, the 
molecular basis for how ER participates in 
NRF1 activation needs further investigation.
Biswas and Chan (2010) have reported 
that NRF1 and NRF2 have over  lapping 
roles in regulating basal expression of ARE­
dependent genes. In the present study we 
found that basal and inducible expression 
of some ARE­driven genes, such as GCLC, 
GCLM, and NQO1, are highly dependent on 
NRF1. However, the induction of HMOX1 
by high concentrations of iAs3+ was indepen­
dent of NRF1, suggesting that HMOX1 is 
not regulated by NRF1. It should be noted 
that NRF1/NRF2­independent mechanisms 
for iAs3+­induced expression of GCLC and 
GCLM have been demon  strated in murine 
hepato  cytes and mouse embryo fibro  blasts 
(Thompson et al. 2009). This inconsistency 
with the present study suggests that forms of 
human and mouse NRF1 behave differently 
or, more likely, reflects differences between the 
cell types evaluated in in vitro assays. As with 
NRF2, NRF1 has been postulated to inter­
act with KEAP1 (Biswas and Chan 2010), 
although the biological significance of this 
reaction is poorly charac  terized. In the present 
work, lack of NRF1 in HaCaT cells did not 
disturb iAs3+­induced NRF2 accumulation 
but noticeably decreased KEAP1 protein lev­
els under basal and iAs3+­exposed conditions, 
suggesting a potential inter  action between 
NRF1 and KEAP1. If KEAP1 could serve as a 
negative regulator of NRF1, decreased KEAP1 
expression caused by NRF1 silencing may rep­
resent a compensation mechanism to maintain 
the overall cellular ARE activity. However, this 
hypothesis needs further investigation.
In the present study, we found convinc­
ing evidence that NRF1 is involved in the 
regulation of the ARE gene battery induced by 
iAs3+ and contributes to the resistance against 
iAs3+­induced cyto  toxicity and apoptosis. 
Importantly, we demonstrated arsenic activa­
tion of NRF1 in a human skin cell line, impli­
cating an NRF1­mediated oxidative stress 
response cascade as an important event in a 
potential target cell of arsenic carcinogenesis. 
Given the potential importance of oxidative 
stress in arsenic dermal toxicity and carcino­
genicity, as well as the critical role of NRF1 
in the defense against oxidative damage, our 
findings provide an important insight into the 
mechanism of chronic arsenic dermal toxicity.
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